1. Home
  2. BAND vs IVVD Comparison

BAND vs IVVD Comparison

Compare BAND & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bandwidth Inc.

BAND

Bandwidth Inc.

HOLD

Current Price

$17.81

Market Cap

395.6M

Sector

Technology

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$1.60

Market Cap

437.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAND
IVVD
Founded
2000
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
395.6M
437.1M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
BAND
IVVD
Price
$17.81
$1.60
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$20.40
$8.75
AVG Volume (30 Days)
335.9K
3.6M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
79.02
EPS
N/A
N/A
Revenue
$204,113,000.00
$53,426,000.00
Revenue This Year
$15.16
$147.67
Revenue Next Year
$6.18
$22.76
P/E Ratio
N/A
N/A
Revenue Growth
25.26
110.47
52 Week Low
$11.33
$0.46
52 Week High
$18.65
$3.07

Technical Indicators

Market Signals
Indicator
BAND
IVVD
Relative Strength Index (RSI) 59.63 53.06
Support Level $14.98 $1.41
Resistance Level $18.63 $1.77
Average True Range (ATR) 1.01 0.15
MACD -0.10 0.05
Stochastic Oscillator 71.38 71.43

Price Performance

Historical Comparison
BAND
IVVD

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: